The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
What about a proportion of salaries and other company admin costs? I would say figure would be closer 25-30 for break even
I agree and have a feeling the zubs have let us bleed long enough and will make their move sooner rather than later. IMO obviously
Would this not be a good price for zubs to take us over
Thanks for reply cp
Hi all, not really been following and updating my spreadsheets on this recently. What’s our current cash and if solo make a producing purchase is this likely to come from existing cash or fund raise?
Hi knowledgables, Just having a quick look here before I maybe take a position. What’s the status via our funding for drills and rest 2019? I’m gonna do two days solid research on the weekend but if someone give brief opinion would be appreciated? Hard luck on bis drill so far guys hope this next one comes big
I think tanz assets bought for slight premium to the aex offer as we can just be bleeded out. I’d think 40-50m
X2.25 is crude measurement of buy/sale though. It doesn’t account for all the expenditure around the project which more than likely exceeds the profit margin on the sale. Just compare the profit against some of the board salaries taken in the interim between purchase and sale. This cannot be defined as a successful disposal.
Hey all, just a quick one when are we expecting the production figures? Cheers
225% profit quoted is very simplistic, cost vs sale. What about all the wages over the years and time and other fees associated with its maintenance within the company portfolio??? It’s can hardly be deemed a successful conclusion as we have done chuff all with it. The company seems to be selling everything off and winding down imo
Revenue streams being the most important imo